Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
granulocyte transfusion
- Development stage
- Unknown
- Lead developer
- Lift BioSciences
- Modality
- Cell Therapies
- Administration
- Intravenous
01
Overview
Granulocyte transfusion is a cellular therapy that involves collecting granulocytes (primarily neutrophils) from healthy donors and transfusing them into patients with severe neutropenia who have developed bacterial or fungal infections that are unresponsive to antimicrobial treatment[1][5]. The primary goal is to provide sufficient functioning granulocytes to combat infections until the patient's own bone marrow recovers and can produce adequate neutrophils[8].
- Other names
- granulocyte infusion
Beyond the preview
Go deeper on granulocyte transfusion.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on granulocyte transfusion.